Compare Eli Lilly And Co (LLY) vs Schlumberger NV (SLB) Price & Performance

Eli Lilly And CoTrade

Schlumberger NVTrade

Price performance (Past 24H)

Key statistics

Eli Lilly And Co vs Schlumberger NV — how do they compare? Eli Lilly And Co trades at $1,214.01 (market cap $1.08T), while Schlumberger NV trades at $53.7 (market cap $79.67B). The key difference: Eli Lilly And Co is far larger — about 13.6× Schlumberger NV's market cap, and Schlumberger NV pays the higher dividend (2.2%). Which is the better fit depends on your goals.

	LLY	SLB
Market Cap	$1.08T	$79.67B
Sector	Health	Energy
52-Week High	$1.24K	$58.01
52-Week Low	$639.43	$31.72
Enterprise Value	$1.13T	$88.40B
Dividend Yield	0.57%	2.2%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LLY

Eli Lilly sues six U.S. entities over illegal black-market retatrutide sales.PRNewsWire · 6 hours agoNeutral Eli Lilly posts strong Q2 with revenue beat and raises full-year guidance, stock up nearly 10% last week.24/7 Wall Street · 1 day agoBullish Eli Lilly adopts Veeva Vault CRM globally to enhance medicine delivery using AI.PRNewsWire · 1 day agoBullish View details →

SLB

SCHD ETF's index reshuffle caused unexpected high taxable distributions in 2024, hitting taxable accounts hard.24/7 Wall Street · 17 hours agoNeutral View details →

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

About Schlumberger NV

Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.